Thymic adult T-cell acute lymphoblastic leukemia stratified in standard- and high-risk group by aberrant HOX11L2 expression: Experience of the German multicenter ALL study group

Leukemia

Volumn 22, Issue 6, 2008, Pages 1154-1160

  Baak, U ^a   Gokbuget N ^b   Orawa, H ^a   Schwartz, S ^a   Hoelzer, D ^b   Thiel, E ^a   Burmeister, T ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HOX PROTEIN; HOX11 PROTEIN; HOX11L2 PROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; GERMANY; HIGH RISK PATIENT; HIGH RISK POPULATION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTOR; T CELL LEUKEMIA; TREATMENT PLANNING;

EID: 45149118226     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2008.52     Document Type: Article

References (25)

1. Pui CH, Relling MV, Downing JR. Acute lymphoblastic leukemia. N Engl J Med 2004; 350: 1535-1548.
2. Annino L, Vegna ML, Camera A, Specchia G, Visani G, Fioritoni G et al Treatment of adult acute lymphoblastic leukemia (ALL): Longterm follow-up of the GIMEMA ALL 0288 randomized study. Blood 2002; 99: 863-871.
3. Gokbuget N, Hoelzer D, Arnold R, Bohme A, Rartram CR, Freund M et al Treatment of adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL). Hematol Oncol Clin North Am 2000; 14: 1307-1325.
4. Thoma X, Boiron JM, Huguet F, Dombret H, Bradstock K, Vey N et al. Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial. J Clin Oncol 2004; 22: 4075-4086.
5. Pui CH, Evans WE. Acute lymphoblastic leukemia. N Engl J Med 1998; 339: 605-615.
6. Ferrando AA, Neuberg DS, Staunton J, Loh ML, Huard C, Raimondi SC et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 2002; 1: 75-87.
7. Ballerini, P, Blaise A, Busson-Le Coniat M, Su XY, Zucman-Rossi J, Adam M et al. HOX11L2 expression, defines a clinical subtype of pediatric T-ALL associated with poor prognosis. Blood 2002; 100 991-997.
8. Cave H, Suciu S, Preudhomme C, Poppe B, Robert A, Uyttebroeck A et al Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: Results of EORTC studies 58881 and 58951. Blood 2004; 103: 442-450.
9. Asnafi V, Beldjord K, Libura M, Villarese P, Millien C, Ballerini P et al. Age-related phenotypic and oncogenic differences in T-cell acute lymphoblastic leukemias may reflect thymic atrophy. Blood 2004; 104: 4173-4180.
10. van Grotel M, Meijerink JP, Beverloo HB, Langerak AW, Buys-Gladdines JG, Schneider P et al. The outcome of molecular-cytogenetic subgroups in pediatric T-cell acute lymphoblastic leukemia: A retrospective study of patients treated according to DCOG or COALL protocols. Haematologica 2006; 91: 1212-1221.
11. Drexler HG, Matsuo AY, MacLeod RA. Continuous hematopoietic cell lines as model systems for leukemia-lymphoma research. Leuk Res 2000; 24: 881-911.
12. Morikawa S, Tatsumi E, Baba M, Harada T, Yasuhira K. Two Erosette-forming lymphoid cell lines. Int J Cancer 1978; 21: 166-170.
13. Beillard E, Pallisgaard N, van der Velden VH, Bi W, Dee R, van der Schoot E et al. Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program. Leukemia 2003; 17 2474-2486.
14. Gökbuget N, Raff R, Brügge-Mann M, Flohr T, Scheuring U, Pfeifer H et al. Risk/MRD adapted GMALL trials in adult ALL. Ann Hematol 2004; 83: S129-S131.
15. Bernard OA, Busson-LeConiat M, Ballerini P, Mauchauffé M, Della Valle V, Monni R et al. A new recurrent and specific cryplic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia. Leukemia 2001; 15: 1495-1504.
16. Hélias C, Leymarie V, Entz-Werle N, Falkenrodt A, Eyer D, Costa JA et al. Translocation t(5;14)(q35;q32) in three cases of childhood T cell acute lymphoblastic leukemia: A new recurring and cryptic abnormality. Leukemia 2002; 16: 7-12.
17. Ferrando AA, Neuberg DS, Dodge RK, Paietta E, Larson RA, Wiernik PH et al. Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia. Lancet 2004; 363: 535-536.
18. Mauvieux L, Leymarie V, Helias C, Perrusson N, Falkenrodt A, Lioure B et al. High incidence of Hox11L2 expression in children with T-ALL. Leukemia 2002; 16: 2417-2422.
19. Asnafi V, Buzyn A, Thomas X, Huguet F, Vey N, Boiron JM et al. Impact of TCR status and genotype on outcome in adult T-cell acute lymphoblastic leukemia: A LALA-94 study. Blood 2005; 105: 3072-3078.
20. Kennedy MA, Gonzalez-Sarmiento R, Kees UR, Lampert F, Dear N, Boehm T et al. Hox11, a homeobox-containing t-cell oncogene on human chromosome-10Q24. Proc Natl Acad Sci USA 1991; 88: 8900-8904.
21. Hatano M, Roberts CWM, Minden M, Crist WM, Korsmeyer SJ. Deregulation of a homeobox gene, Hox11, by the T(10-14) in T-cell leukemia. Science 1991; 253: 79-82.
22. Schneider NR, Carroll AJ, Shuster JJ, Pullen DJ, Link MP, Borowitz MJ et al. New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: A pediatric oncology group report of 343 cases. Blood 2000; 96: 2543-2549.
23. Kees U R, Heerema NA, Kumar R, Watt PM, Baker DL, La MK et al. Expression of HOX11 in childhood T-lineage acute lymphoblastic leukaemia can occur in the absence of cytogenetic aberration at 10q24: A study from the Children's Cancer Group (CCG). Leukemia 2003; 17: 887-893.
24. Chiaretti S, Li X, Gentleman R, Vitale A, Vignetti M, Mandelli F et al. Gene expression profile of adult T-cell acute lymphocytic leukemia identifies distinct subsets of patients with different response to therapy and survival. Blood 2004; 103: 2771-2778.
25. Zhu YM, Zhao WL, Fu JF, Shi JY, Pan Q, Hu J et al. NOTCH1 mutations in T-cell acute lymphoblastic leukemia: Prognostic significance and implication in multifactorial leukemogenesis. Clin Cancer Res 2006; 12: 3043-3049.